File:AstraZeneca.svg · Wikimedia Commons · See Wikimedia Commons
AstraZeneca
Sign in to saveAlso known as AstraZeneca plc., AZ
I don't have any context provided to base an overview of AstraZeneca on. To write an accurate, neutral overview based only on factual information you've provided, I would need context material about the company. Could you please share the context you'd like me to use?
AI-generated from the Wikipedia summary — may contain errors.
Key facts
- Company.revenue
- US$58.739 billion (2025)
- Company.operating_income
- US$13.743 billion (2025)
- Company.net_income
- US$10.233 billion (2025)
- Company.equity
- US$48.719 billion (2025)
- Company.num_employees
- 89,900 (2025)
- Company.name
- AstraZeneca plc
- Company.logo
- AstraZeneca.svg
- Company.image
- Astra-Zeneca-Central-Cambridge.jpg
- Company.image_caption
- AstraZeneca's headquarters in Cambridge
- Company.type
- Public
- Company.hq_location_city
- Cambridge
- Company.hq_location_country
- England
- Company.area_served
- Global
via Wikipedia infobox
Company
AZN- Industry
- Pharmaceutical Preparations
- Exchange
- NYSE
- State of incorporation
- X0
- Entity type
- other
- Latest filing
- 6-K · 2026-06-01
- Jurisdiction
- GB
- Headquarters
- CAMBRIDGE, GB
Research organization · ROR
- Type
- Company, Funder
- Founded
- 1999
- Location
- Cambridge, United Kingdom
- Status
- Active
GRID grid.417815.e · ISNI 0000 0004 5929 4381
Described at
History of AstraZeneca PLC – FundingUniverse
Explore the history, profile and timeline of AstraZeneca PLC.
fundinguniverse.com →Link to a page describing this subject · 31,212 chars · not written by Vinony
Wikidata facts
- Official name
- Zeneca Group PLC
- Employees
- 61100
- Revenue
- 24708000000
- Official website
- www.astrazeneca.com
- Image
- AstraZeneca HQ in Cambridge UK.jpg
Show 9 more facts
- Commons category
- AstraZeneca
- inception
- 1913-00-00
- social media followers
- 304575
- net profit
- 2826000000
- total assets
- 60056000000
- operating income
- 4116000000
- total equity
- 18509000000
- carbon footprint
- 6037418
Sources (15)
via Wikidata · CC0
~35 min read
Article
37 sectionsContents
- History
- 2000–2006
- 2007–2012: The patent cliff and subsequent acquisitions
- 2013 restructuring and beyond
- 2013
- 2014
- 2015
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- Acquisition history
- Operations
- Headquarters
- Cambridge-Gothenburg flights
- Orphan drugs
- Senior management
- Lobbying
- Political lobbying
- Controversies
- Seroquel
- Nexium
- Bildman fraud, sexual harassment and faithless servant clawback
- CAFÉ study
- Transfer mispricing
- Conflicting commitments to the UK and the EU over COVID-19 vaccines
- Operations in China and investigation
- Operations in Russia
- See also
- References
- External links
AstraZeneca plc () (AZ) is a Swedish-British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group (itself formed by the demerger of the pharmaceutical operations of Imperial Chemical Industries in 1993). Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). It has its research and development concentrated in three strategic centres: Cambridge, UK; Gothenburg, Sweden; and Gaithersburg, Maryland, US.